Biotech Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-1 Trial of VK2735 November 19, 2025
Biotech Piramal Pharma Solutions’ Bioconjugates Facility in Grangemouth, UK Receives Updated MHRA GMP Certificates November 19, 2025
Biotech Amorepacific Named CES Innovation Award Honoree for Advanced Electronic Skin Platform November 15, 2025
Biotech Onward Therapeutics Completes Share Exchange and Establishes Global Headquarters in Taiwan November 11, 2025
Biotech Leucid Bio Provides Update on Phase I/IIa AERIAL Trial Evaluating Lateral CAR-T LEU011 for the Treatment of Solid Tumours November 10, 2025
Biotech AusperBio Announces Late-Breaking 48-Week Phase II Data of AHB-137 in Chronic Hepatitis B at AASLD 2025 November 9, 2025
Biotech ACAAI 2025 | CS2015 (OX40L/TSLP Bispecific Antibody) Makes International Debut November 7, 2025
Biotech Onassis Holdings Appoints Esq. Paz Itzhaki-Weinberger to Advisory Board to Oversee International Law and Trade November 5, 2025